Dow Up 0.07% Nasdaq Up 0.17%

Oncothyreon Inc (ONTY)

-NasdaqGS
1.83 Down 0.07(3.68%) 12:01PM EDT - Nasdaq Real Time Price
Prev Close:1.90
Open:1.91
Bid:1.83 x 9500
Ask:1.84 x 1600
1y Target Est:3.50
Beta:1.63
Next Earnings Date:N/A
Day's Range:1.83 - 1.91
52wk Range:1.67 - 4.08
Volume:185,044
Avg Vol (3m):754,832
Market Cap:129.58M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ONTYDown 3.68%129.58M
GSKUp 2.28%107.18B
RHHBYUp 0.41%248.29B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:08-May-95

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oncothyreon Inc, a clinical-stage biopharmaceutical company, develops therapeutic products for the treatment of cancer. Its product candidate includes Tecemotide, a vaccine for the treatment of non-small cell lung cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback